Source
128 releases originally issued via SEC EDGAR. The issuing organizations are responsible for their content.
Oral, highly selective and potent VAV1 molecular glue degrader designed to deliver a differentiated clinical profile across a broad range of…
Third Quarter 2026 Financial Results
Q3 Net Revenue Increased 257% to $298.7 Million
Company raises full-year revenue and earnings outlook again and increases full-year cash flow expectations
Victory Capital Reports Strong Third Quarter 2026 Results, Highlighted by Record Gross Sales and Net Flows
Achieves 30% Revenue Growth Year-Over-Year
•Global Net Revenue of $78.0 Million for the Third Quarter of 2026, an Increase of 13% Over the Prior Year, Supported by Double-Digit Growth in…
Raises Mid-Point of Full-Year 2026 Revenue Guidance Following Solid Execution
Raises FY 2026 Sales and Adjusted EPS Outlook on Continued Strong Demand Across Its Diversified End Markets
Reported Third Quarter of 2026 Net Income of $8.8 million, Adjusted EBITDA of $38.7 million and Distributable Cash Flow of $21.8 million compared to…
Third quarter revenue increased 14% year-over-year to $1,722 million
Q3 revenue grew 43% year-over-year to $391.4 million, $16.4 million above the high-end of prior guidance.
Excelerate Energy Reports Strong Third Quarter 2026 Results